Aevi Genomic Medicine, Llc, A Cerecor Company

This early-stage study tested a new oral medicine called NFC-1 in 30 teenagers with ADHD who have specific genetic changes. The main goals were to check if the medicine was safe, how the body processes it, and to look for early signs it might help control ADHD symptoms. Researche…